Creative Biolabs is at the forefront of liposome drug delivery systems to meet the expanding need for targeted delivery in research.
SHIRLEY, NY, June 24, 2025 /24-7PressRelease/ — Liposomes, lipid bilayer vesicles shaped as spheres, are a novel drug delivery vehicle that has gained the potential to deliver hydrophobic and hydrophilic molecules. Creative Biolabs is at the forefront of this technology, providing one-stop lipid-based delivery services to meet varying client needs.
“We offer several advanced platforms and technologies to support lipid-based drug delivery research. Alongside our flagship LipoDrive™ Platform, other available platforms include microfluidics technology, which ensures precise control over liposome and nanoparticle formation, achieving uniform particle sizes and encapsulation efficiency,” said the manager of the liposome research department.
To optimize drug delivery systems, Creative Biolabs has developed a series of liposome types, including conventional, PEGylated, and cationic liposomes. They are designed to enhance biologic stability and release profile, providing pharmaceutical industries with the products they require to overcome traditional drug development challenges.
The company has also diversified its products, making available access to innovative liposome products across a range of applications that include anticancer therapies and vaccines up to gene delivery systems. Liposome utilization in these applications not only improves drug solubility and stability but also provides targeted delivery with lower off-target effects.
“We are excited about the progress we are making in liposome R&D,” said one of Creative Biolabs’ scientists. “Our team is dedicated to building on the forefront of lipid-based delivery platforms so that we can bring our customers the latest solutions for their therapeutic needs. The possibilities of liposomes to revolutionize drug therapies in the years to come are enormous, and we don’t want to be on the sidelines.”
Besides its development service, this company offers a complete set of liposome-based delivery applications to meet diverse industry demands from biomedicine to agriculture. These include but are not limited to liposomes for drugs, liposomes for cosmetics, and liposomes for veterinary medicine.
“Whether your aim is to improve drug delivery, improve product performance, or discover next-generation applications, our experienced team is available to assist your vision with tailored solutions and end-to-end technical support,” stated the scientist.
As the biopharmaceutical industry continues to advance, the role of liposomes is expanding dramatically. Creative Biolabs is dedicated to advancing liposome technologies, meeting the industry’s urgent needs, and driving medicine forward.
For more information about liposome development services and products offered by Creative Biolabs, go to https://www.creative-biolabs.com/lipid-based-delivery/.
About Creative Biolabs
Creative Biolabs is a leading biotech company worldwide with a focus on providing one-stop drug development and delivery services. Focusing on innovation and customer satisfaction, the company offers diversified services and products to enable more efficient research.
—
For the original version of this press release, please visit 24-7PressRelease.com here
